Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

I appreciate AMG's due diligence, although to answer your question directly, the reason they are aggressively pursuing the use of this drug in Asia as opposed to American (for treatment of Coronavirus) is there are fewer hoops to jump through as it's sold there. In America they will need FDA approval. In Asia, they could solidify a deal with a CRO who works with the physicians who are on the ground treating these sick patients and they could "fast track" past ethics and essentially start treating patients right away because of the severity of the situation.

This drug could be the go to drug for mortality reduction in patients with Acute Respiratory Distress Syndrome (a result of acute lung injury/inflammation caused by the virus).

WATCH THE NEWS RELEASE TODAY, these guys just announced they WILL CONSIDER USING THIS DRUG IN PATIENTS WITH INFLUENZA. HUGE. And they have the patents... they are protected .

This is going to be in the dollars range in no time.

Congrats to everyone who's been long. We have hit the jackpot.